Login / Signup

Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.

Ping-Hsien LeeTori N YamamotoDevikala GurusamyMadhusudhanan SukumarZhiya YuJane Hu-LiTakeshi KawabeArunakumar GangaplaraRigel J KishtonAmanda N HenningSuman Kumar VodnalaRonald N GermainWilliam E PaulNicholas P Restifo
Published in: The Journal of experimental medicine (2019)
Host conditioning has emerged as an important component of effective adoptive cell transfer-based immunotherapy for cancer. High levels of IL-1β are induced by host conditioning, but its impact on the antitumor function of T cells remains unclear. We found that the administration of IL-1β increased the population size and functionality of adoptively transferred T cells within the tumor. Most importantly, IL-1β enhanced the ability of tumor-specific T cells to trigger the regression of large, established B16 melanoma tumors in mice. Mechanistically, we showed that the increase in T cell numbers was associated with superior tissue homing and survival abilities and was largely mediated by IL-1β-stimulated host cells. In addition, IL-1β enhanced T cell functionality indirectly via its actions on radio-resistant host cells in an IL-2- and IL-15-dependent manner. Our findings not only underscore the potential of provoking inflammation to enhance antitumor immunity but also uncover novel host regulations of T cell responses.
Keyphrases